Showing results 1-10 of 23 For: Chawnshang Chang

Advanced search »

  1. Induction of TR4 Orphan Receptor by Retinoic Acid in Human HaCaT Keratinocytes

    Shigeki Inui, Yi-Fen Lee, Anne R Haake, Lowell A Goldsmith, Chawnshang Chang

    Journal of Investigative Dermatology 112, 426-431 (April 1999) doi:10.1046/j.1523-1747.1999.00548.x

  2. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase

    Hui-Kuan Lin, Liang Wang, Yueh-Chiang Hu, Saleh Altuwaijri, Chawnshang Chang

    The EMBO Journal 21, 4037-4048 (1 August 2002) doi:10.1093/emboj/cdf406 Article

  3. Identification of Androgen-Inducible TGF-β1 Derived from Dermal Papilla Cells as a Key Mediator in Androgenetic Alopecia

    Shigeki Inui, Yoko Fukuzato, Takeshi Nakajima, Kunihiko Yoshikawa, Satoshi Itami

    Journal of Investigative Dermatology Symposium Proceedings 8, 69-71 (June 2003) doi:10.1046/j.1523-1747.2003.12174.x Original Article

  4. Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway

    Soo Ok Lee, Wei Lou, Min Hou, Sergio A Onate, Allen C Gao

    Oncogene 22, 7981-7988 (11 September 2003) doi:10.1038/sj.onc.1206735 Original Paper

  5. hZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication foci

    Manju Sharma, Xiaoyu Li, Yuzhuo Wang, Mark Zarnegar, Chun-Yin Huang, Jorma J. Palvimo, Bing Lim, Zijie Sun

    The EMBO Journal 22, 6101-6114 (17 November 2003) doi:10.1093/emboj/cdg585 Article

  6. Androgen signaling is required for the vitamin D-mediated growth inhibition in human prostate cancer cells

    Bo-Ying Bao, Yueh-Chiang Hu, Huei-Ju Ting, Yi-Fen Lee

    Oncogene 23, 3350-3360 (29 March 2004) doi:10.1038/sj.onc.1207461 Original Paper

  7. RRR-α-tocopheryl succinate inhibits human prostate cancer cell invasiveness

    Min Zhang, Saleh Altuwaijri, Shuyuan Yeh

    Oncogene 23, 3080-3088 (15 April 2004) doi:10.1038/sj.onc.1207435 Original Paper

  8. Does androgen deprivation improve treatment outcomes in patients with low-risk and intermediate-risk prostate cancer?

    Hiroshi Miyamoto, Edward M Messing, Chawnshang Chang

    Nature Clinical Practice Oncology 2, 236-237 (May 2005) doi:10.1038/ncponc0168 Practice Point

  9. Does androgen deprivation improve treatment outcomes in patients with low-risk and intermediate-risk prostate cancer?

    Hiroshi Miyamoto, Edward M Messing, Chawnshang Chang

    Nature Clinical Practice Oncology 2, 236-237 (May 2005) doi:10.1038/ncponc0168 Practice Point

  10. Expression and function of human steroid receptor RNA activator in prostate cancer cells: role of endogenous hSRA protein in androgen receptor-mediated transcription

    T Kurisu, T Tanaka, J Ishii, K Matsumura, K Sugimura, T Nakatani, H Kawashima

    Prostate Cancer and Prostatic Diseases 9, 173-178 (11 April 2006) doi:10.1038/sj.pcan.4500867 Original Article


Extra navigation

ADVERTISEMENT

Search for Chawnshang Chang in: